The global multimodal imaging market was valued at $4.4 billion in 2022, and is projected to reach $7.9 billion by 2032, growing at a CAGR of 6.1% from 2023 to 2032. Multimodal imaging refers to the use of multiple imaging techniques or modalities to capture different types of information about a subject. In the field of medical imaging, it often involves combining data from various imaging technologies, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET). By combining information from multiple modalities, multimodal imaging allows a comprehensive understanding of the target, as each modality highlights different aspects or characteristics. This leads to improved accuracy in diagnosis, treatment planning, and monitoring of various conditions. The integration of data from different sources provides a more comprehensive view of complex systems, enabling researchers and professionals to gain insights that are not achievable with a single imaging modality.
The rise in prevalence of chronic diseases, such as cancer and cardiovascular disorders, necessitates advanced imaging solutions for early detection, accurate diagnosis, and monitoring of disease progression which contributes toward the multimodal imaging market growth. For instance, in 2023, American Cancer Society estimated that around 1,958,310 new cancer cases is expected to be diagnosed in U.S. In addition, ongoing advancements in imaging technologies contribute to the growth of multimodal imaging. As individual modalities improve in terms of resolution, speed, and sensitivity, the combination of these technologies becomes even more powerful, offering enhanced capabilities for comprehensive imaging. Conversely, the high cost of the multimodal imaging devices limit the adoption and negatively impact the market growth. On the other hand, growth opportunities in emerging markets and rise in technological advancements in imaging systems provide lucrative opportunities for market growth.
The multimodal imaging market is segmented into technology, application, end user, and region. By technology, the market is segregated into PET/CT systems, PET/MR systems, SPECT/CT systems, and others. By application, the market is categorized into brain & neurology, cardiology, oncology, ophthalmology, and others. By end user, the market is classified into hospitals, diagnostic imaging centers, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
Major key players that operate in the multimodal imaging market are GE Healthcare, Koninklijke Philips N.V., Canon Inc., Siemens, Topcon Corporation, Bruker Corporation, Spectrum Dynamics Medical, Mediso Ltd., MR Solutions, and Neusoft Corporation. Key players have adopted expansion, acquisition, product approval, partnership, and agreement as key developmental strategies to improve the product portfolio of the multimodal imaging market. For instance, in July 2021, Topcon Corporation announced that it has acquired VISIA Imaging S.r.l, an ophthalmic device manufacturer headquartered in suburban Florence, Italy.
The rise in prevalence of chronic diseases, such as cancer and cardiovascular disorders, necessitates advanced imaging solutions for early detection, accurate diagnosis, and monitoring of disease progression which contributes toward the multimodal imaging market growth. For instance, in 2023, American Cancer Society estimated that around 1,958,310 new cancer cases is expected to be diagnosed in U.S. In addition, ongoing advancements in imaging technologies contribute to the growth of multimodal imaging. As individual modalities improve in terms of resolution, speed, and sensitivity, the combination of these technologies becomes even more powerful, offering enhanced capabilities for comprehensive imaging. Conversely, the high cost of the multimodal imaging devices limit the adoption and negatively impact the market growth. On the other hand, growth opportunities in emerging markets and rise in technological advancements in imaging systems provide lucrative opportunities for market growth.
The multimodal imaging market is segmented into technology, application, end user, and region. By technology, the market is segregated into PET/CT systems, PET/MR systems, SPECT/CT systems, and others. By application, the market is categorized into brain & neurology, cardiology, oncology, ophthalmology, and others. By end user, the market is classified into hospitals, diagnostic imaging centers, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
Major key players that operate in the multimodal imaging market are GE Healthcare, Koninklijke Philips N.V., Canon Inc., Siemens, Topcon Corporation, Bruker Corporation, Spectrum Dynamics Medical, Mediso Ltd., MR Solutions, and Neusoft Corporation. Key players have adopted expansion, acquisition, product approval, partnership, and agreement as key developmental strategies to improve the product portfolio of the multimodal imaging market. For instance, in July 2021, Topcon Corporation announced that it has acquired VISIA Imaging S.r.l, an ophthalmic device manufacturer headquartered in suburban Florence, Italy.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the multimodal imaging market analysis from 2022 to 2032 to identify the prevailing multimodal imaging market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the multimodal imaging market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global multimodal imaging market trends, key players, market segments, application areas, and market growth strategies.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Key Market Segments
By Technology
- PET/CT Systems
- PET/MR Systems
- SPECT/CT Systems
- Others
By Application
- Brain and Neurology
- Cardiology
- Oncology
- Ophthalmology
- Others
By End User
- Hospitals
- Diagnostic Imaging Centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- GE Healthcare
- Mediso Ltd.
- MR Solutions
- Topcon Corporation
- Siemens
- Koninklijke Philips N.V.
- Bruker Corporation
- Canon Inc.
- Neusoft Corporation
- Spectrum Dynamics Medical, LLC
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY
CHAPTER 5: MULTIMODAL IMAGING MARKET, BY APPLICATION
CHAPTER 6: MULTIMODAL IMAGING MARKET, BY END USER
CHAPTER 7: MULTIMODAL IMAGING MARKET, BY REGION
CHAPTER 8: COMPETITIVE LANDSCAPE
CHAPTER 9: COMPANY PROFILES
List of Tables
List of Figures
Companies Mentioned
- GE Healthcare
- Mediso Ltd.
- MR Solutions
- Topcon Corporation
- Siemens
- Koninklijke Philips N.V.
- Bruker Corporation
- Canon Inc.
- Neusoft Corporation
- Spectrum Dynamics Medical, LLC
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 260 |
| Published | November 2023 |
| Forecast Period | 2022 - 2032 |
| Estimated Market Value ( USD | $ 4.4 billion |
| Forecasted Market Value ( USD | $ 7.9 billion |
| Compound Annual Growth Rate | 6.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
